腹膜外腹腔镜与腹膜外 Senhance 根治性前列腺切除术的比较。
Comparison of extraperitoneal laparoscopic and extraperitoneal Senhance radical prostatectomy.
机构信息
Department of Urology, University Hospital Center Zagreb, Zagreb, Croatia.
School of Medicine, University of Zagreb, Zagreb, Croatia.
出版信息
Int J Med Robot. 2022 Feb;18(1):e2344. doi: 10.1002/rcs.2344. Epub 2021 Nov 3.
BACKGROUND
Senhance is novel robotic platform which can be used to perform radical prostatectomy (RP). We compare our results of robotic RP to similar patients operated with laparoscopic technique.
PATIENTS AND METHODS
A prospective study of 61 patients operated laparoscopically and 107 patients operated using the Senhance robotic system. We have analysed operative and postoperative results in both groups.
RESULTS
There was no difference in the operative time, estimated blood loss, positive surgical margins, length of hospitalisation and catheterisation. There were 4 (6.5%) Clavien-Dindo grade I complications, and 5 (8.1%) late complications in laparoscopy. There were 6 (5.6%) Clavien-Dindo grade I, 3 (2.8%) grade II, 1 (0.9%) grade IV complications and 2 (1.9%) late complications in robotic group.
CONCLUSION
Senhance robot-assisted RP is safe, feasible and offers good and comparable functional and oncological outcomes to laparoscopy. The transition to robotic surgery with a relatively fast learning curve can be done effectively for surgeons with previous laparoscopic experience.
背景
Senhance 是一种新型的机器人平台，可用于进行根治性前列腺切除术（RP）。我们将 Senhance 机器人系统辅助 RP 的结果与采用腹腔镜技术的类似患者进行了比较。
患者和方法
前瞻性研究了 61 例行腹腔镜手术和 107 例行 Senhance 机器人系统手术的患者。我们分析了两组患者的手术和术后结果。
结果
手术时间、估计失血量、阳性手术切缘、住院时间和导管留置时间均无差异。腹腔镜组有 4 例（6.5%）Clavien-Dindo I 级并发症和 5 例（8.1%）迟发性并发症。机器人组有 6 例（5.6%）Clavien-Dindo I 级、3 例（2.8%）II 级、1 例（0.9%）IV 级并发症和 2 例（1.9%）迟发性并发症。
结论
Senhance 机器人辅助 RP 安全、可行，可提供与腹腔镜相当的良好的功能和肿瘤学结果。对于具有腹腔镜经验的外科医生来说，具有相对较快学习曲线的机器人手术的过渡可以有效地进行。
Zotero 插件